Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 36

Sort by

Sort Order Select

Journal Articles

Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors

Blood (2016) 127 (7): 938–947.

https://doi.org/10.1182/blood-2015-09-671834

Published: 2016

Includes: Supplemental data

Journal Articles

Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity?

Blood (2012) 120 (20): 4256–4262.

https://doi.org/10.1182/blood-2012-06-436725

Published: 2012

Includes: Supplemental data

Journal Articles

Results of Allogeneic Hematopoietic Cell Transplantation in Persons with Fanconi Anemia and Pretransplant Cytogenetic Abnormalities, Myelodysplastic Syndrome, or Acute Leukemia

Mouhab Ayas, Jennifer Le-Rademacher, PhD, H. Joachim Deeg, M.D., Robert Peter Gale, MD, PhD, DSc, Stella M. Davies, MBBS, PhD, Rajinder PS Bajwa, MBBS, MD, MRCP, Minoo Battiwalla, MD, MS, Shimon Slavin, MD, Bruce Camitta, MD, Marc B Bierings, MD, PhD, Richard E. Harris, MD, Richard Olsson, MD PhD MMSc, Baldeep Wirk, MD, Biju George, MD, Carmem Bonfim, MD, Wael Saber, MD, MS

Blood (2011) 118 (21): 838.

https://doi.org/10.1182/blood.V118.21.838.838

Published: 2011

Journal Articles

Is There a Role for ASCT in Patients with Desmoplastic Small Round Cell Tumor of the Peritoneum?

Rachel J Cook, MD, MS, Zhiwei Wang, MS, Mukta Arora, MD, Hillard M. Lazarus, MD, Kimberly A. Kasow, DO, Martin A. Champagne, MD, FRCPC, Wael Saber, MD, MS, Koen M. Van Besien, MD, Gregory A. Hale, MD, Edward A. Copelan, MD, Mohamed Elmongy, MD, DSc, Naoto T Ueno, MD, Biljana N. Horn, MD, Shimon Slavin, MD, Edward A. Stadtmauer, MD

Blood (2011) 118 (21): 3092.

https://doi.org/10.1182/blood.V118.21.3092.3092

Published: 2011

Journal Articles

Allogeneic hematopoietic stem cell transplantation in children and adolescents with recurrent and refractory Hodgkin lymphoma: an analysis of the European Group for Blood and Marrow Transplantation

Alexander Claviez, Carme Canals, Daan Dierickx, Jerry Stein, Isabel Badell, Andrea Pession, Stephen Mackinnon, Shimon Slavin, Jean-Hugues Dalle, Manuel Jurado Chacón, Mahmoud Sarhan, Robert Francis Wynn, Meinolf Suttorp, Giorgio Dini, Anna Sureda, Norbert Schmitz

Blood (2009) 114 (10): 2060–2067.

https://doi.org/10.1182/blood-2008-11-189399

Published: 2009

Journal Articles

Early and Effective Immune-Recovery by Gene-Engineered Lymphocytes after Haploidentical Transplantation for Leukemia Abate Late Transplant Mortality

Blood (2008) 112 (11): 353.

https://doi.org/10.1182/blood.V112.11.353.353

Published: 2008

Journal Articles

Intra-Arterial Catheter Directed Immunosuppressive Therapy for Steroid Resistant or Dependent Graft vs. Host Disease (GVHD).

Michael Y. Shapira, MD, Allan I. Bloom, MD, Reuven Or, MD, Igor B. Resnick, MD, PhD, DSc, Memet Aker, MD, Shimon Slavin, MD, Anthony Verstandig, MD

Blood (2007) 110 (11): 4960.

https://doi.org/10.1182/blood.V110.11.4960.4960

Published: 2007

Journal Articles

Simultaneous Haploidentically Mismatched Stem Cell Transplantation from Multi-Donors (MDT) in Humans Offers Better Engraftment as Compared to Single Haploidentical Donor.

Michael Y. Shapira, MD, Igor B. Resnick, MD DSc PhD, Benjamin Gesundeheidt, MD PhD, Simcha Samuel, MSc, Liliane Drey, RN, Yuri Verkholevsky, RN BA, Shimon Slavin, MD, Reuven Or, MD

Blood (2007) 110 (11): 4854.

https://doi.org/10.1182/blood.V110.11.4854.4854

Published: 2007

Journal Articles

Thymoglobulin ® Rabbit Anti-Thymocyte Globulins (r-ATG) Induces Faster Platelet Recovery and Does Not Suppress Granulocyte Engraftment in a Non-Myeloablative Stem Cell Transplantation Setting.

Michael Y. Shapira, MD, Igor B. Resnick, MD PhD DSc, Benjamin Gesundeheidt, MD PhD, Menachem Bitan, Aliza Ackerstein, MSc, Simcha Samuel, MSc, Liliane Drey, RN BA, Yuri Verkholevsky, RN BA, Shimon Slavin, MD, Reuven Or, MD

Blood (2007) 110 (11): 4942.

https://doi.org/10.1182/blood.V110.11.4942.4942

Published: 2007

Journal Articles

The Impact of Allogeneic Hematopoietic Stem Cell Transplantation in Children and Adolescents with Recurring Hodgkin’s Lymphoma: An EBMT Study on 151 Patients.

Alexander Claviez, MD, Carmen Canals, Marc Boogaerts, MD, Jerry Stein, MD, Stephen Mackinnon, MD, Rodrigo Martino, MD, Andrea Pession, MD, Shimon Slavin, MD, Charles Craddock, MD, Ioanna Sakellari, MD, Paolo Corradini, MD, Alessandro Rambaldi, MD, Meinolf Suttorp, MD, Giorgio Dini, MD, Anna Sureda, MD, Norbert Schmitz, MD

Blood (2007) 110 (11): 3061.

https://doi.org/10.1182/blood.V110.11.3061.3061

Published: 2007

Journal Articles

A phase 2/3 multicenter randomized clinical trial of ABX-CBL versus ATG as secondary therapy for steroid-resistant acute graft-versus-host disease

Margaret L. MacMillan, Daniel Couriel, Daniel J. Weisdorf, Gisela Schwab, Nancy Havrilla, Thomas R. Fleming, Saling Huang, Lorin Roskos, Shimon Slavin, Richard K. Shadduck, John DiPersio, Mary Territo, Steve Pavletic, Charles Linker, Helen E. Heslop, H. Joachim Deeg, Bruce R. Blazar

Blood (2006) 109 (6): 2657–2662.

https://doi.org/10.1182/blood-2006-08-013995

Published: 2006

Journal Articles

Transplantation from Related and Unrelated Donors in Elderly Patients - Equal Toxicity and Survival.

Michael Y. Shapira, MD, Panagiotis D. Tsirigotis, MD PhD, Reuven Or, MD, Igor B. Resnick, MD PhD, Menachem Bitan, MD, Benjamin Gesundheit, MD PhD, Shimon Slavin

Blood (2006) 108 (11): 5256.

https://doi.org/10.1182/blood.V108.11.5256.5256

Published: 2006

Journal Articles

N-Acetylcysteine Mildly Inhibits the Graft vs Leukemia Effect but Not the Lymphokine Activated Cells (LAK) Activity.

Michael Y. Shapira, MD, Lola Weiss, PhD, Shoshana Reich, Michael Zeira, PhD, Shimon Slavin, MD

Blood (2006) 108 (11): 5171.

https://doi.org/10.1182/blood.V108.11.5171.5171

Published: 2006

Journal Articles

Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myelogenous Leukemia.

Michael Y. Shapira, MD, Tsirigotis D. Panagiotis, MD PhD, Reuven Or, MD, Igor B. Resnick, MD PhD, Benjamin Gesundheit, MD, Shimon Slavin, MD

Blood (2006) 108 (11): 3038.

https://doi.org/10.1182/blood.V108.11.3038.3038

Published: 2006

Journal Articles

Induction of Anti-Cancer Effects by Targeting Alloreactive Intentionally Mismatched T Cells and NK Cells to Tumor Cells Using Bi-Specific Trifunctional Antibodies.

Shoshana Morecki, PhD, Horst Lindhofer, PhD, Elena Yacovlev, Yael Gelfand, MSc, Shimon Slavin, MD

Blood (2006) 108 (11): 3245.

https://doi.org/10.1182/blood.V108.11.3245.3245

Published: 2006

Journal Articles

Assessment of the Immune Reconstitution by Cylex Immuknow™ Assay in Patients after Allogeneic Stem Cell Transplantation.

Benjamin Gesundheit, MD, PhD, Yehudit Azar, PhD, Rachel Bringer, BSc, Schivti Steinberg-Prop, MSc, Moshe Israeli, BSc, Michael Y. Shapira, MD, Igor Resnick, MD, Simcha Samuel, MSc, Shimon Slavin, MD, Reuven Or, MD

Blood (2006) 108 (11): 3219.

https://doi.org/10.1182/blood.V108.11.3219.3219

Published: 2006

Journal Articles

Enhancement of Hematopoietic Stem Cell Engraftment and Graft vs. Leukemia Effect Induced by Matched and Haploidentically Mismatched Allograft Using Multi-Donor Stem Cell Transplantation (MDT).

Michael Y. Shapira, MD, Reuven Or, MD, Igor B. Resnick, MD PhD, Simcha Samuel, MSc, Benjamin Gesundheit, MD PhD, Shimon Slavin, MD

Blood (2006) 108 (11): 3663.

https://doi.org/10.1182/blood.V108.11.3663.3663

Published: 2006

Journal Articles

Rapid and Wide Immunereconstitution Obtained with HSV-TK Engineered Donor Lymphocyte Add-Backs Permits Long-Term Survival after haplo-HSCT.

Blood (2006) 108 (11): 307.

https://doi.org/10.1182/blood.V108.11.307.307

Published: 2006

Journal Articles

Amplification of Graft vs Malignancy (GVM) Effects by Using Intentionally Mismatched Donor Lymphocytes While Avoiding Graft-vs-Host Disease in Conjunction with Haploidentically Mismatched Stem Cell Allografts in Patients with Hematological Malignances.

Shimon Slavin, MD, Michael Y. Shapira, MD, Igor B. Resnick, MD, Menachem Bitan, MD, Memet Aker, MD, Simcha Samuel, MSc, Shoshana Morecki, PhD, Reuven Or, MD

Blood (2006) 108 (11): 5157.

https://doi.org/10.1182/blood.V108.11.5157.5157

Published: 2006

NARROW

Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors

Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity?

Results of Allogeneic Hematopoietic Cell Transplantation in Persons with Fanconi Anemia and Pretransplant Cytogenetic Abnormalities, Myelodysplastic Syndrome, or Acute Leukemia

Is There a Role for ASCT in Patients with Desmoplastic Small Round Cell Tumor of the Peritoneum?

Allogeneic hematopoietic stem cell transplantation in children and adolescents with recurrent and refractory Hodgkin lymphoma: an analysis of the European Group for Blood and Marrow Transplantation

Early and Effective Immune-Recovery by Gene-Engineered Lymphocytes after Haploidentical Transplantation for Leukemia Abate Late Transplant Mortality

Intra-Arterial Catheter Directed Immunosuppressive Therapy for Steroid Resistant or Dependent Graft vs. Host Disease (GVHD).

Simultaneous Haploidentically Mismatched Stem Cell Transplantation from Multi-Donors (MDT) in Humans Offers Better Engraftment as Compared to Single Haploidentical Donor.

Thymoglobulin ® Rabbit Anti-Thymocyte Globulins (r-ATG) Induces Faster Platelet Recovery and Does Not Suppress Granulocyte Engraftment in a Non-Myeloablative Stem Cell Transplantation Setting.

The Impact of Allogeneic Hematopoietic Stem Cell Transplantation in Children and Adolescents with Recurring Hodgkin’s Lymphoma: An EBMT Study on 151 Patients.

A phase 2/3 multicenter randomized clinical trial of ABX-CBL versus ATG as secondary therapy for steroid-resistant acute graft-versus-host disease

Transplantation from Related and Unrelated Donors in Elderly Patients - Equal Toxicity and Survival.

N-Acetylcysteine Mildly Inhibits the Graft vs Leukemia Effect but Not the Lymphokine Activated Cells (LAK) Activity.

Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myelogenous Leukemia.

Long-Term Safety and Efficacy of Stem Cell Gene Therapy for ADA-SCID.

Induction of Anti-Cancer Effects by Targeting Alloreactive Intentionally Mismatched T Cells and NK Cells to Tumor Cells Using Bi-Specific Trifunctional Antibodies.

Assessment of the Immune Reconstitution by Cylex Immuknow™ Assay in Patients after Allogeneic Stem Cell Transplantation.

Enhancement of Hematopoietic Stem Cell Engraftment and Graft vs. Leukemia Effect Induced by Matched and Haploidentically Mismatched Allograft Using Multi-Donor Stem Cell Transplantation (MDT).

Rapid and Wide Immunereconstitution Obtained with HSV-TK Engineered Donor Lymphocyte Add-Backs Permits Long-Term Survival after haplo-HSCT.

Amplification of Graft vs Malignancy (GVM) Effects by Using Intentionally Mismatched Donor Lymphocytes While Avoiding Graft-vs-Host Disease in Conjunction with Haploidentically Mismatched Stem Cell Allografts in Patients with Hematological Malignances.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only